Immune disease comorbidities

ASTHMA_IMMUNECOMORB

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
ASTHMA_IMMUNECOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 29510 18722 10788
Unadjusted prevalence (%) 9.56 10.79 7.99
Mean age at first event (years) 48.97 47.71 51.17

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.98 [1.69, 2.33] 9.9e-17 2969
15 years 0.01 1.19 [1.01, 1.40] 3.5e-2 1284
5 years 0.00 2.32 [2.04, 2.64] 1.6e-37 768
1 year 0.00 5.98 [5.11, 6.99] <1e-100 398

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ASTHMA_IMMUNECOMORB – Immune disease comorbidities
GWS hits:

Survival analyses between endpoints

Plot

before Immune disease comorbidities
after Immune disease comorbidities

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Immune disease comorbidities